Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Izotropic ( (TSE:IZO) ).
Izotropic’s newly formed Casablanca-based venture, Izotropic Africa, is being structured to license, market, and distribute the IzoView Breast CT Imaging System and follow-on products across Africa and the Gulf Cooperation Council, with Izotropic holding a 40% stake alongside a local business group. The initiative aligns the company with regional healthcare priorities and leverages Morocco’s strategic location and industrial infrastructure to support regional expansion.
Izotropic Africa has entered partnership discussions with the Mohammed VI Foundation for Science & Health to collaborate on clinical research, regulatory advancement, and potential manufacturing and assembly of IzoView systems in Morocco. The talks include placing a US$500,000 IzoView unit at a leading Moroccan hospital for clinical evaluation, positioning Izotropic to benefit from Morocco’s new national framework to build domestic medical device manufacturing capacity, strengthen supply chains, and promote export-oriented production.
The most recent analyst rating on (TSE:IZO) stock is a Hold with a C$0.20 price target. To see the full list of analyst forecasts on Izotropic stock, see the TSE:IZO Stock Forecast page.
Spark’s Take on TSE:IZO Stock
According to Spark, TipRanks’ AI Analyst, TSE:IZO is a Neutral.
The score is mainly pressured by very weak financial performance (no revenue, persistent losses, negative free cash flow, and negative equity). Technical indicators also point to a bearish trend with weak momentum. Valuation provides limited offset since the company is loss-making (negative P/E) and has no dividend yield data.
To see Spark’s full report on TSE:IZO stock, click here.
More about Izotropic
Izotropic Corporation is a medical device company developing imaging-based technologies to improve the screening, diagnosis, and treatment of breast cancer. Through its proprietary IzoView Breast CT Imaging System and related products, the company is targeting global healthcare markets, with a growing focus on emerging regions such as Africa and the Gulf Cooperation Council states.
Average Trading Volume: 39,501
Technical Sentiment Signal: Sell
Current Market Cap: C$15.59M
See more data about IZO stock on TipRanks’ Stock Analysis page.